PPIDT00404
Drug Information
| Name | Brolucizumab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB14864 |
| Type | biotech |
| Indication | Brolucizumab is a monoclonal antibody indicated to treat neovascular age related macular degeneration.[A187208,L9089] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Intravitreal |
120 MG/ML
|
| Injection, solution | Intravitreal |
6 mg/0.05mL
|
| Solution | Intravitreal |
6 mg / 0.05 mL
|
| Solution | Intravitreal |
120 mg/ml
|
| Solution | Intraocular |
6.000 mg
|
| Solution | Intraocular |
120 mg
|
| Solution | Intraocular |
12000000 mg
|